期刊文献+

应用DNA280免疫吸附器治疗系统性红斑狼疮的观察 被引量:12

The clinical observation of DNA280 immunoadsorbent on 3 systemic lupus erythematosus
在线阅读 下载PDF
导出
摘要 目的观察DNA280免疫吸附器治疗系统性红斑狼疮(systemic lupus erythematosus,SLE)的效果。方法选取30例系统性红斑狼疮患者,运用DNA280免疫吸附器治疗,检测吸附治疗前后抗核抗体(ANA)、抗双链DNA抗体(ds-DNA)、IgA、IgG、IgM的抗体滴度变化、补体C3、C4、血常规、电解质、肾功能、肝功能等指标并行统计学分析。结果免疫吸附治疗后,患者ANA、ds-DNA抗体滴度明显减少(P<0.05);血常规及其他各项生化指标无明显改变,无肝肾功能损害(P>0.05),临床症状有不同程度的缓解。结论DNA280免疫吸附器对系统性红斑狼疮治疗有效,能减少ANA、ds-DNA滴度水平,并且安全、无明显副反应。 Objective To observe clinical effect of DNA280 immunoadsorbent on systemic lupus erythematosus(SLE) patients. Methods Strictly according to the standard of inclusion and exclusion, selecting 30 patients with SLE patients to accept immunoadsorption therapy and detect the titres of ANA and ds-DNA in pre treatment and after treatment, Morever, the concen trations of IgA, IgG、 IgM antibody , C3、 C4 and the change of blood routine 、 electro lyre , renal function、hepatic function , then analyzed results by statistics, P〈0. 05 was considered as significant difference. Results the titres of ANA and ds DNA decreased after treatment which was significant difference compared with pretreatment(P〈0. 05): the param eters of bloodroutine, biochemical indicator remained static without obvious liver and nephron function loss. The clinical symptoms were improved. Conclusion DNA280 immunoadsorbent has definitely better therapeutic effect which can exclusively decrease the levels of ANA、ds-DNA. The immunoadsorption is safe and no obvious side effects.
出处 《中国血液净化》 2005年第12期649-651,共3页 Chinese Journal of Blood Purification
关键词 DNA280免疫吸附器 免疫吸附 系统性红斑狼疮 抗核抗体(ANA) 抗双链DNA抗体(ds-DNA) DNA280 inmunoadsorbent Inmunoadsorption Systemic lupus erythematosus Antinuclear antibody(ANA) Anti DNA antibody(ds DNA)
作者简介 通讯作者:娄探奇
  • 相关文献

参考文献3

二级参考文献33

  • 1王质刚.欧洲第一次蛋白A免疫吸附研讨会纪要[J].中国血液净化,2002,1(1):55-57. 被引量:15
  • 2Van Brubben MC J, Wrlgrcen B, Rijke RPM, et al. Heparin and heparinoids prevent the binding of immune complexes containing nuclesomal antigens to the GBM and delay nephritis in MRL/lpr mice. Kidney Int ,1996, 50:1555-1564.
  • 3Wang Y,Hu O,Madre JA.Amelioration of lupus-like autoimmune disease in NZB/W F 1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci USA, 1996, 93:8563-8568.
  • 4Charles PJ, Smeenk RJT, Dejong J, et al. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha:findings in open-label and randomiz
  • 5Sato EI,Assis LS,Lourenzi VP,et al. Long-term thalidomide use in refraetory cutaneous lesions of systemic lupus erythermatosus. Rev Assoc Med Bras, 1998,44:289-293.
  • 6Clynes R,Dumitru C,Ravetch JV.Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science, 1998,279:1052-1054.
  • 7Balomenos D,Rumold R,Theofilopoulos AN.Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.J Clin Invest, 1998,101:364-371.
  • 8Alvarez NYJ, Cobrarrubias CA, Escalante TF, et al. Bromocriptine in systemic lupus erythematosus: a double-blind randomized, placebo-controlled study. Lupus ,1998, 7:414-419.
  • 9Van Vollenhoven RF, Park JL, Genovese MC, et al. A double-blind,placebo-controlled, clinical trial of dehydrcepiandrosterone in severe systemic lupus erythematosus. Lupus, 1999,8:181 - 187.
  • 10Blanco R, Martinez VM, Redriguezvalverde V, et al. Successful therapy with danazol in refractory autoimmune thrombocytopoenia associated with rheumatic diseases. Br J Rheumatol,1997, 36:1095-1099.

共引文献62

同被引文献60

  • 1滕杰,陈利明,邹建洲,吉俊,方艺,丁小强,章晓燕,徐少伟,钟一红,傅辰生,袁敏.蛋白A免疫吸附治疗急进性肾炎-附5例报告[J].中国血液净化,2005,4(9):472-475. 被引量:8
  • 2李明,胡海蓉,冯玉明,袁美茹,李舸,李明霞.血浆置换联合DNA免疫吸附血液灌流治疗难治性系统性红斑狼疮[J].中国危重病急救医学,2005,17(12):739-739. 被引量:19
  • 3张静波,张耀全,刘敏,杨惠标,黄唯麟,梁莉,郭晓霞,王代红,郭艳红,陈枫,黄拥军.DNA免疫吸附治疗狼疮性肾炎的临床观察[J].中国血液净化,2006,5(1):27-29. 被引量:29
  • 4付洁,宋海峰.核酸疫苗的药动学与安全性研究进展[J].中国新药杂志,2006,15(5):337-340. 被引量:4
  • 5郑智华,余学清.肾脏病学2008年学术年会专题汇编[A].2008:252-253.
  • 6Kong D, Schuett W, Dai J , et al. Development of cellulose-DNA immunoadsorbent [ J ]. Artif Organs, 2002, 26 ( 2 ) : 200-208.
  • 7Gaubitz M, Schneider KM. Immunoadsorption in systemic lupus erythematosus: different techniques and their current role in medical therapy [ J ]. Ther apher Dial,2003,7 (2) : 183-188.
  • 8Kong D,Schuett W,Dai J,et al.Development of cellulose-DNA immunoadsorbent[J].Artif Organs,2002,26(2):200-208.
  • 9Stummvoll GH,Aringer M,Smolen JS.IgG immunoadsorption(IAS) reduces SLE activity and proteinuria-a long term observational study[J].Ann Rheum Dis,2005:64(7):1015-1021.
  • 10Vila LM, Molina MJ, Mayor AM, et al. Clinical and prognostic val- ue of autoantibodies in puertoricans with systemic lupus erytherna- tosus[J]. Lupus, 2006,15 (12) : 892 - 898.

引证文献12

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部